Peregrine Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-384,608
| Closed | -$3.63M | – | 330 |
|
|
2023
Q3 | $3.63M | Sell |
384,608
-23,478
| -6% | -$222K | 0.11% | 240 |
|
|
2023
Q2 | $5.7M | Sell |
408,086
-140
| -0% | -$1.96K | 0.16% | 234 |
|
|
2023
Q1 | $7.66M | Buy |
408,226
+11,622
| +3% | +$218K | 0.22% | 201 |
|
|
2022
Q4 | $5.46M | Sell |
396,604
-11,666
| -3% | -$161K | 0.17% | 228 |
|
|
2022
Q3 | $7.81M | Sell |
408,270
-22,553
| -5% | -$431K | 0.25% | 184 |
|
|
2022
Q2 | $6.57M | Buy |
430,823
+74
| +0% | +$1.13K | 0.2% | 224 |
|
|
2022
Q1 | $8.77M | Sell |
430,749
-31,647
| -7% | -$645K | 0.21% | 200 |
|
|
2021
Q4 | $13.5M | Buy |
462,396
+12,935
| +3% | +$377K | 0.27% | 118 |
|
|
2021
Q3 | $9.7M | Buy |
449,461
+118,463
| +36% | +$2.56M | 0.2% | 213 |
|
|
2021
Q2 | $8.49M | Buy |
+330,998
| New | +$8.49M | 0.15% | 245 |
|